BTEK.L vs. VOO
Compare and contrast key facts about iShares Nasdaq US Biotechnology UCITS ETF (BTEK.L) and Vanguard S&P 500 ETF (VOO).
BTEK.L and VOO are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. BTEK.L is a passively managed fund by iShares that tracks the performance of the NASDAQ Biotechnology TR USD. It was launched on Oct 19, 2017. VOO is a passively managed fund by Vanguard that tracks the performance of the S&P 500 Index. It was launched on Sep 7, 2010. Both BTEK.L and VOO are passive ETFs, meaning that they are not actively managed but aim to replicate the performance of the underlying index as closely as possible.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: BTEK.L or VOO.
Key characteristics
| BTEK.L | VOO | |
|---|---|---|
| YTD Return | 1.74% | 11.83% |
| 1Y Return | 5.99% | 31.13% |
| 3Y Return (Ann) | 2.31% | 10.03% |
| 5Y Return (Ann) | 6.72% | 15.07% |
| Sharpe Ratio | 0.45 | 2.60 |
| Daily Std Dev | 15.00% | 11.62% |
| Max Drawdown | -30.86% | -33.99% |
| Current Drawdown | -9.97% | 0.00% |
Correlation
The correlation between BTEK.L and VOO is 0.40, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
BTEK.L vs. VOO - Performance Comparison
In the year-to-date period, BTEK.L achieves a 1.74% return, which is significantly lower than VOO's 11.83% return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
BTEK.L vs. VOO - Expense Ratio Comparison
BTEK.L has a 0.35% expense ratio, which is higher than VOO's 0.03% expense ratio.
Risk-Adjusted Performance
BTEK.L vs. VOO - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for iShares Nasdaq US Biotechnology UCITS ETF (BTEK.L) and Vanguard S&P 500 ETF (VOO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
BTEK.L vs. VOO - Dividend Comparison
BTEK.L has not paid dividends to shareholders, while VOO's dividend yield for the trailing twelve months is around 1.32%.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
BTEK.L iShares Nasdaq US Biotechnology UCITS ETF | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
VOO Vanguard S&P 500 ETF | 1.32% | 1.46% | 1.69% | 1.25% | 1.54% | 1.88% | 2.06% | 1.78% | 2.02% | 2.10% | 1.85% | 1.84% |
Drawdowns
BTEK.L vs. VOO - Drawdown Comparison
The maximum BTEK.L drawdown since its inception was -30.86%, smaller than the maximum VOO drawdown of -33.99%. Use the drawdown chart below to compare losses from any high point for BTEK.L and VOO. For additional features, visit the drawdowns tool.
Volatility
BTEK.L vs. VOO - Volatility Comparison
iShares Nasdaq US Biotechnology UCITS ETF (BTEK.L) has a higher volatility of 4.81% compared to Vanguard S&P 500 ETF (VOO) at 3.49%. This indicates that BTEK.L's price experiences larger fluctuations and is considered to be riskier than VOO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.